Seed VC · Amsterdam
Curie Capital invests in early-stage Life Sciences companies with a focus on therapeutics, diagnostics, or class IIb and III medical devices, bringing 'more to the table than capital' by helping portfolio companies build their organizations.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers
Geography
Europe
+ 1 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Curie Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. Claude Fundraiser tracks Curie Capital alongside 45,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 45,000+ active investors in the database by fit. Curie Capital is one of them — and we'll tell you exactly where they sit in your top 100.